Ligand validation:4RV8

IMP: INOSINIC ACID

IMP is a Ligand Of Interest in 4RV8 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RV8_IMP_D_501	90%	35%	0.085	0.968	1.39	1.28	2	3	1	0	100%	1
4RV8_IMP_A_500	90%	33%	0.091	0.973	1.44	1.33	2	4	1	0	100%	1
4RV8_IMP_C_501	88%	35%	0.101	0.976	1.41	1.25	2	3	1	0	100%	1
4RV8_IMP_B_501	83%	34%	0.1	0.96	1.45	1.25	2	2	1	0	100%	1
4IXH_IMP_B_502	82%	33%	0.119	0.976	1.39	1.37	2	5	0	0	100%	1
4QJ1_IMP_D_501	82%	35%	0.118	0.974	1.38	1.27	2	3	1	0	100%	1
3KHJ_IMP_B_804	75%	29%	0.121	0.956	1.57	1.38	2	5	0	0	100%	1
2C6Q_IMP_E_1337	98%	21%	0.06	0.984	1.94	1.53	5	6	3	0	100%	1
5UWX_IMP_C_501	98%	35%	0.06	0.984	1.3	1.35	3	2	2	0	100%	1
5UZC_IMP_D_500	98%	31%	0.06	0.981	1.35	1.51	2	3	1	0	100%	1
5UPV_IMP_A_601	98%	35%	0.06	0.979	1.39	1.27	2	3	1	0	100%	1
7PVO_IMP_A_501	97%	33%	0.063	0.981	1.48	1.28	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.